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Abstract
Background: Fat accumulation in android compartments may confer increased metabolic risk. The incremental utility of
measuring regional fat deposition in association with metabolic syndrome (MS) has not been well described particularly in
an elderly population.
Methods and Findings: As part of the Korean Longitudinal Study on Health and Aging, which is a community-based cohort
study of people aged more than 65 years, subjects (287 male, 75.968.6 years and 278 female, 76.068.8 years) with regional
body composition data using Dual energy X-ray absorptiometry for android/gynoid area, computed tomography for
visceral/subcutaneous adipose tissue (VAT/SAT), and cardiometabolic markers including adiponectin and high-sensitivity
CRP were enrolled. We investigated the relationship between regional body composition and MS in multivariate regression
models. Mean VAT and SAT area was 131.4665.5 cm
2 and 126.9655.2 cm
2 in men (P=0.045) and 120.0646.7 cm
2 and
211.8665.9 cm
2 in women (P,0.01). Mean android and gynoid fat amount was 1.860.8 kg and 2.560.8 kg in men and
2.060.6 kg and 3.360.8 kg in women, respectively (both P,0.01). VAT area and android fat amount was strongly correlated
with most metabolic risk factors compared to SAT or gynoid fat. Furthermore, android fat amount was significantly
associated with clustering of MS components after adjustment for multiple parameters including age, gender, adiponectin,
hsCRP, a surrogate marker of insulin resistance, whole body fat mass and VAT area.
Conclusions: Our findings are consistent with the hypothesized role of android fat as a pathogenic fat depot in the MS.
Measurement of android fat may provide a more complete understanding of metabolic risk associated with variations in fat
distribution.
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Introduction
Obesity is a heterogeneous disorder characterized by multi-
factorial etiology. Obese individuals vary in their body fat
distribution, their metabolic profile and the degree of associated
cardiovascular and metabolic risks. There is substantial evidence
providing that fat distribution is a better predictor of cardiovas-
cular disease than the degree of obesity [1–5]. An excess of
abdominally located fat, even without manifestations of obesity, is
associated with metabolic disturbances that indicate an increased
risk of atherogenesis and of higher morbidity and mortality,
possible due to inherent characteristics of abdominal adipocytes
[3,4,6,7]. Thus, regional fat distribution rather than overall fat
volume has been considered to be more important in under-
standing the link between obesity and metabolic disorders.
Among fat depots, fat accumulation in the abdominal area has a
greater risk of developing diabetes and future cardiovascular
events than the peripheral area [8]. There are differences
between adipose tissue present in subcutaneous areas and in the
abdominal cavity. These include anatomical, cellular, molecular,
physiological, clinical and prognostic differences [2,7,9]. Many
studies have suggested that visceral adipose tissue (VAT) com-
pared with subcutaneous adipose tissue (SAT) is more cellular,
vascular and innervated with a larger number of inflammatory
and immune cells, lesser preadipocyte differentiating capacity,
and a greater percentage of large adipocytes [9]. Similar findings
were also observed across different races/ethnicities including
Japanese where an independent association with VAT was found
even after accounting for multiple risk factors [7]. Therefore, fat
distribution rather than its magnitude may be more significant in
understanding metabolic risk, particularly the varying impacts of
VAT and SAT.
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e27694In a different context, truncal fat depot can be partitioned into
upper body (android or central) and lower body (gynoid or
peripheral) area. Empirically, android or central fat deposition is
known to be more associated with cardiometabolic risk than
gynoid or peripheral fat deposition. Many studies with simple
anthropometric measurements such as waist circumference or
waist-to-hip ratio have given more weight to the central adiposity
[6,10–12]. More advanced technology with computed tomogra-
phy (CT) or dual energy X-ray absorptiometry (DXA) has been
used to measure the regional fat mass. CT has an advantage in
distinguishing between VAT and SAT while DXA can measure
compartment body compositions such as android and gynoid area.
However, there are limited studies investigating the implication of
android/gynoid fat deposition assessed by advanced technology in
determining cardiometabolic risks.
Metabolic syndrome (MS) increases cardiovascular morbidity
and mortality, and all cause of mortality [13]. MS also increases
the risk of developing diabetes mellitus with its components re-
presenting major risk factors for impaired glucose metabolism
[14]. Obesity, particularly abdominal obesity, is a key feature of a
cluster of atherothrombotic and inflammatory abnormalities
associated with MS [15]. There is substantial evidence linking
central obesity with cardiovascular disease and the other MS
components as well as its critical role in the etiological cascade
leading to full-blown manifestations of MS.
Thus, assessment of fat distribution may be important in the
clinical evaluation of cardiometabolic risks. However, there has
been no comprehensive study on fat distribution related risks
particularly in elderly Asian populations whose physical and meta-
bolic characteristics differ from those of Caucasians. We evaluated
the association between clustering of components constituting MS
and the whole and regional body composition measured by com-
prehensive methods including DXA and CT in a community-
based cohort study of elderly men and women. The effects of
metabolic or inflammatory markers were also evaluated.
Methods
Subjects, anthropometric and biochemical parameters
This study was part of the Korean Longitudinal Study on
Health and Aging (KLoSHA), which is a cohort that began in
2005 and consisted of 1000 Korean subjects aged over 65 years
(439 men and 561 women) recruited from Seongnam city, one of
the satellites of Seoul Metropolitan district. The study population
and part of the method of measurements for the cohort have been
published previously [16].
The current study subjects were from the KLoSHA. Of the
original 1000 KLoSHA subjects, we randomly selected 600
participants (60% of the KLoSHA subjects) for assessment of
body composition. Of these 600 subjects, 21 declined the DXA or
CT scans and 14 were unable to undergo the examination due to
their poor physical condition. In total, 565 participants (94.2% of
600 selected subjects) who underwent DXA/CT scans for body
composition evaluation were enrolled in the current analysis. Per-
tinent demographic and other characteristics of the selected
subjects were similar to the cohort population. Among study
participants, 39.1% (n=221) were found to have diabetes: 17.5%
(n=99) were previously on antidiabetic medication and 21.6%
(n=122) were diagnosed with diabetes by 75 g standard OGTT
which was performed as s study screening procedure. Smoking
and alcohol status was divided into three categories; current smo-
ker, ex-smoker, or never smoker, and current drinker, ex-drinker,
or never drinker, respectively. Current drinker was defined as a
person consuming more than 4 drinks/week (50 g/day of ethanol).
Physical activity was divided into two categories; none or regular
exercise. Regular exercise was defined as exercising more than
three times a week (each session should be at least 30 min long).
The homeostasis model assessment of the insulin resistance
(HOMA-IR) was calculated as reported previously [17]. Several
metabolic markers including adiponectin and high-sensitivity CRP
(hsCRP) which are known to be associated with MS were mea-
sured. Detailed information about measurement method was
published previously [16]. MS was defined according to the NCEP
guideline as the presence of at least three of the following com-
ponents: abdominal obesity (waist circumference $90 cm for men
and $80 cm for women), triglyceride level $150 mg/dL, high-
density lipoprotein cholesterol level ,40 mg/dL for men and
,50 mg/dL for women, blood pressure $135/85 mmHg, and/or
fasting blood glucose level $110 mg/dL [18]. All the assessments
were performed at Seoul National University Bundang Hospital
(SNUBH). This was approved by the Institutional Review Board
of SNUBH. The written, informed consent for subjects undergo-
ing CT procedure to inform them of radiation hazard and possible
contrast toxicity was obtained from each individual as a routine
procedure.
Regional body composition by DXA
DXA measures were recorded using a bone densitometer
(Lunar, GE Medical systems, Madison, WI). DXA is quantified by
body tissue absorption of photons that are emitted at two energy
levels to resolve body weight into bone mineral, lean and fat soft
tissue masses. In vivo precision for body composition measure-
ments using DXA was proven previously [19]. In this study,
precision was excellent for lean tissue mass (root mean square of
0.21 kg; coefficient of variation (CV) of 0.4%) and precision error
for the total fat mass had a CV 0.86% and 0.88% for the
percentage fat. A high correlation between consecutive measure-
ments was observed for all three compartment body compositions
including total body bone mineral content, lean mass, and fat mass
(standard error of=0.99321.002; all r
2=0.99).
The regions of interest (ROI) for regional body composition
were defined using the software provided by the manufacturer
(Figure 1A):
N Trunk ROI (T): from the pelvis cut (lower boundary) to the
neck cut (upper boundary).
N Android fat distribution ROI (A): from the pelvis cut (lower
boundary) to above the pelvis cut by 20% of the distance
between the pelvis and neck cuts (upper boundary).
N Umbilicus ROI (U): from the lower boundary of central fat
distribution ROI to a line by 1.5 times the height of the
android fat distribution ROI (lower boundary).
N Gynoid fat distribution ROI (G): from the lower boundary of
umbilicus ROI (upper boundary) to a line equal to twice the
height of the android fat distribution ROI (lower boundary).
Abdominal (visceral and subcutaneous) fat areas by CT
CT scans were obtained using a 64–detector (Brilliance; Philips
Medical Systems, Cleveland, Ohio). All patients were placed in the
supine position and were scanned from L3-4 to L5-S1 inter-
vetebral disc level. The tube voltage was 120 kVp for 64 detector
row scanner. Effective tube current-time product generally ranged
between 20–50 mAs. The images were reconstructed with 5 mm
thickness with 5 mm-intervals. One slice obtained at the level of
umbilicus were selected and the amount of the total abdominal fat
were calculated by measuring the area of the pixels whose
attenuation values ranged from 2190 to 230 Hounsfield unit
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2.8, Infinitt Co., Seoul) [20]. VAT was defined as fat area confined
to the abdominal wall musculature. After subtracting VAT from
total fat area, the remainder was defined as SAT (Figure 1B).
Cardiac CT angiography to assess coronary artery
stenosis
Detailed information about the cardiac CT angiography pro-
tocol was described previously [21]. Briefly, CT angiography was
performed with a 64-slice multidetector-row cardiac CT scanner
(Brilliance 64; Philips Medical Systems, Best, The Netherlands),
and a standard scanning protocol was used [21]. All scans
were analyzed independently in a blind fashion using a three-
dimensional workstation (Brilliance; Philips Medical Systems).
Each lesion was identified using a multiplanar reconstruction
technique and maximum intensity projection of the short axis, in
two-chamber and four-chamber views. Coronary artery lesions
were analyzed according to the modified American Heart
Association classification [22].
Statistical analyses
All data are presented as the mean and SD or n and %,
and were analyzed using SPSS Windows version 11.0 (SPSS Inc.,
Chicago, IL). The demographic and laboratory characteristics of
subjects were compared using Student’s t test or a Chi-square test
according to the presence of MS. Correlations between variables
were analyzed using Pearson’s correlation. Multiple regression
analysis was used to determine the independent effect of body
composition parameters on clustering of five components of MS.
P,0.05 was considered significant.
Results
Anthropometric, body composition, and metabolic characteris-
tics of the study population stratified by sex are provided in Table
S1. Men (n=287) and women (n=278) in our study were of
similar age. Mean age (6 SD) of study subjects was 73.667.6 years
for men and 72.566.7 years for women. BMI (6 SD) was
24.163.2 kg/m
2 for men and 24.663.1 kg/m
2 for women. Men
were more likely to have unfavorable lifestyle habits including
smoking and alcohol consumption, nevertheless the proportion of
participants who engaged in regular exercise was significantly
higher in men than in women. The concentrations of HDL- and
LDL-cholesterol, and adiponectin were significantly greater in
women whereas fasting plasma glucose concentration were higher
in men. There was no significant difference in the concentration of
triglycerides, fasting insulin, A1C, and hsCRP levels between men
Figure 1. Regional body composition measurement by DXA (A) and CT (B).
doi:10.1371/journal.pone.0027694.g001
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significantly greater in men. Whole body fat mass, android and
gynoid fat amount measured by DXA, and SAT quantified by CT
were significantly higher in women than men. In contrast, VAT
quantified by CT was greater in men than in women (P,0.05).
Comparison of anthropometric characteristics including
body composition in participants with and without
metabolic syndrome (Table 1)
Of the study population of 565 elderly people (73.067.2 years
of age), 47.4% (n=268) fulfilled the criteria of MS. Participants
with or without MS were similar in age, but more women had MS
than men. Systolic and diastolic blood pressure, BMI, and waist
circumference were significantly higher in participants with MS
compared to without MS. In terms of specific adiposity mea-
surements, whole body fat mass, total android and gynoid tissue,
android and gynoid fat amount measured by DXA, and VAT and
SAT quantified by CT scan were all greater in participants with
MS compared to without MS. The concentrations of triglycerides,
and HDL-cholesterol, fasting glucose and insulin, and A1C levels,
and HOMA-IR were significantly higher in participants with MS
than without MS. Circulating adiponectin levels were significantly
lower in participants with MS, whereas hsCRP level was not
significantly different between two groups. In terms of lifestyle
habits, the proportion of subjects with cigarette smoking and alco-
hol consumption were significantly higher in MS. However
participants with MS were more likely to engage in regular
exercise. Past medical history of coronary heart disease (i.e.
angina, myocardial infarction, percutaneous coronary interven-
tion, and coronary artery bypass surgery) or strokes were not
different.
Correlation analysis between regional adiposity including
VAT, SAT, android, and gynoid fat and various variables
(Table 2 and Figure 2)
There was a negative correlation between age and android and
gynoid fat amount (both P,0.01). BMI and waist circumference
were highly correlated with VAT and SAT, and android and
gynoid fat amount (all P,0.01). VAT at the level of umbilicus was
significantly correlated with adiposity measurements by DXA
including whole body fat mass, android and gynoid fat amount.
However, the correlation coefficient was significantly greater
between VAT and android fat than between VAT and gynoid fat
(P,0.05). The concentration of triglycerides was associated with
all of the four adiposity indices including VAT and SAT, and
android and gynoid fat amount whereas HDL-cholesterol showed
negative association with adiposity indices. Android fat amount
was associated with fasting glucose and insulin levels, HOMA-IR,
and A1C, whereas gynoid fat was not associated with fasting
glucose and A1C levels. Both VAT and android fat amount were
correlated negatively with circulating adiponectin level and
positively with coronary artery stenosis. Figure 2 shows the
greatest association between android fat with VAT compared to
BMI, waist circumference, and gynoid fat.
Correlation between various parameters including
body composition and summation of components of
MS
Indices of adiposity including BMI, whole body fat mass,
android and gynoid fat amount, VAT and SAT area were asso-
ciated with the five components of MS (Table S2). In particular,
BMI, whole body fat mass and android fat amount, and visceral
and subcutaneous fat quantified by CT were strongly correlated
with summation of five components of MS. Alanine aminotrans-
ferase and c-glutamyl transferase levels were weakly correlated
with MS, and fasting insulin level and HOMA-IR were more
Table 1. Participants characteristics including body
composition measured by dual energy x-ray absorptiometry
(DXA) and computed tomography (CT).
No MS
(n=268) MS (n=297) P-value
Mean SD Mean SD
Age (years) 72.5 6.9 73.6 7.4 0.067
Male (n, %) 159 59.3% 128 43.1% ,0.001
SBP (mmHg) 128.9 17.7 136.6 16.6 ,0.001
DBP (mmHg) 81.6 11.0 85.0 10.4 ,0.001
BMI (kg/m
2) 23.1 3.0 25.5 2.9 ,0.001
Waist circumference (cm) 82.8 9.0 90.3 7.9 ,0.001
Smoking 0.037
Current smoker (n, %) 37 13.8% 32 10.8%
Ex-smoker (n, %) 89 33.2% 76 25.6%
Never smoker (n, %) 142 53.0% 189 63.6%
Alcohol 0.008
Current drinker (n, %) 89 33.5% 66 22.3%
Ex-drinker (n, %) 41 15.4% 44 14.9%
Never drinker (n, %) 136 51.1% 186 62.8%
Regular exercise (n, %) 166 62.6% 160 54.4% 0.049
Medication
Antihypertensive medication 89 33.2% 160 53.9% ,0.001
Antidiabetic medication 26 9.7% 73 23.6% ,0.001
Lipid lowering medication 30 11.2% 40 13.5% 0.445
By DXA
Whole body muscle mass (kg) 37.1 7.2 36.9 37.1 0.801
Whole body fat mass (kg) 18.5 7.4 24.3 18.5 ,0.001
Android fat mass (kg) 1.6 0.7 2.1 1.6 ,0.001
Gynoid fat mass (kg) 2.6 0.9 3.2 2.6 ,0.001
By CT
Visceral adipose tissue
(cm
2)
103.9 52.9 149.8 55.4 ,0.001
Subcutaneous adipose
tissue (cm
2)
134.2 68.4 189.4 66.8 ,0.001
By cardiac CT
angiography
Coronary artery stenosis (%) 20.1 21.6 25.6 25.2 ,0.001
Biochemical data
Triglycerides (mg/dL) 104.2 41.4 171.6 107.8 ,0.001
HDL-cholesterol (mg/dL) 51.1 12.0 40.5 10.4 ,0.001
LDL-cholesterol (mg/dL) 129.2 33.9 127.4 35.5 0.532
Fasting glucose (mg/dL) 104.9 20.0 117.5 29.0 ,0.001
Fasting insulin (mIU/mL) 4.3 2.1 6.0 3.8 ,0.001
HOMA-IR* 1.1 0.6 1.8 1.2 ,0.001
A1C (%) 5.9 0.7 6.3 1.0 ,0.001
Adiponectin (mg/mL) 10.1 6.1 7.4 5.1 ,0.001
hsCRP (mg/dL) 0.3 0.8 0.2 0.5 0.413
*HOMA-IR; homeostasis model assessment for insulin resistance.
doi:10.1371/journal.pone.0027694.t001
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with clustering of MS components.
Multivariate regression analysis of the relationship
between body composition and metabolic syndrome
(Table 3) and coronary artery stenosis (Table 4)
Multivariate linear regression models were used to assess
whether android fat amount measured by DXA was associated
with the summation of five components of MS (i.e. central obesity,
hypertension, high triglyceride and low HDL-cholesterol, dysgly-
cemia) controlling for VAT quantified by CT. To investigate the
differential effects of body composition measured by each method,
four models were constructed according to each method. In Model
1, age, gender, smoking status, exercise habit, BMI, hsCRP ($
2.5 mg/l vs. ,2.5 mg/l), LDL-cholesterol, adiponectin, HOMA-
IR, and whole body fat mass were selected as independent
variables. In Model 2, VAT area was added as an independent
variable. In Model 3, android fat was further added to Model 1 as
an independent variable. Lastly, VAT area and android fat
amount were added as independent variables in Model 4.
In model 1, age, female gender, BMI, hsCRP and HOMA-IR
were positively associated with clustering of MS components,
whereas adiponectin was negatively associated. Adjusting for VAT
resulted in a positive association of MS with age, female gender,
hsCRP, HOMA-IR, and VAT, and a negative association with
adiponectin (Model 2). Association with BMI was attenuated after
including VAT in the model. Adjusting for android fat with MS,
age, gender, BMI, HOMA-IR, and android fat were positively
associated with MS, and negatively associated with adiponectin
(Model 3). Finally, adjusting for both VAT and android fat in
Model 4 yielded a consistent and unchanged positive association of
android fat with MS, whereas an association with VAT was
attenuated. When the combined VAT area between L3-4 and L5-
S1 was used instead of a single level of VAT (992.3648.7 cm
2 in
men and 1469.4653.7 cm
2 in women, P,0.001), this merged
VAT area was associated with MS with a borderline significance
(Table S3). Including medication history in the regression analysis
did not affect the significant association between android fat/
visceral fat and MS.
We further investigated the association between android fat/
VAT and coronary artery stenosis. In univariate analysis, android
fat and VAT were significantly associated with the degree of
coronary artery stenosis. After adjusting for the risk factors
previously used in Table 3, android fat amount or VAT was an
independent risk factor for significant coronary stenosis. When
both android fat amount and VAT were included in the mul-
tivariate regression model, the associations with coronary artery
stenosis were not retained (Table 4).
Discussion
In this study with community-based elderly population, of the
various body compositions examined using advanced techniques,
android fat and VAT were significantly associated with clustering
of five components of MS in multivariate linear regression analysis
adjusted for various factors. When android fat and VAT were both
included in the regression model, only android fat remained to be
associated with clustering of MS components. The results suggest
that android fat is strongly associated with MS in the elderly
population even after adjusting for VAT.
Abdominal obesity is well recognized as a major risk factor of
cardiovascular disease and type 2 diabetes [11]. Although anth-
ropometric measurements such as BMI and waist circumference
are widely used to estimate abdominal obesity, distinguishing
between visceral and subcutaneous fat or between fat and lean
mass cannot be ascertained. Moreover, anthropometric measure-
ments are subject to intra- and inter-examiner variations.
Alternatively, more accurate methods used to measure regional
fat depot are DXA and CT. DXA and CT provide a com-
prehensive assessment of the component of body composition with
each contributing its unique advantages. CT can distinguish
between visceral and subcutaneous fat, and has been useful in
measuring fat or muscle distribution at specific regions [23,24].
However, there are several limitations in the VAT quantification
using CT scan. Even though VAT from a single scan obtained at
the level of umbilicus was well correlated with the total visceral
volume [25], there could be a potential concern for over- or
underestimation if we measure fat area at one selected level instead
of measuring total fat volume. In addition, CT scan has a greater
risk of radiation hazards than DXA and is not appropriate for
repetitive measurements [20,26].
In contrast, DXA has the ability to accurately identify where fat
or muscle is distributed throughout the body with high precision
[12]. The measurement of body composition is an area, which has
attracted great interest because of the relationships between fat
and lean tissue mass with health and disease. In addition, DXA
Table 2. Correlation analysis between adiposity indices
including visceral and subcutaneous adipose tissue (VAT and
SAT) measured by CT and android and gynoid fat measured
by DXA with various variables.
VAT SAT
Android
fat
Gynoid
fat
Age (years) 20.078 20.111 20.128* 20.167*
BMI (kg/m
2) 0.675** 0.649** 0.773** 0.697**
Waist circumference (cm) 0.598** 0.438** 0.661** 0.450**
By DXA
Whole body muscle mass (kg) 0.314** 20.288** 0.169* 20.111*
Whole body fat mass (kg) 0.696** 0.809** 0.927** 0.945**
Android fat mass (kg) 0.813** 0.684** 1 0.797**
Gynoid fat mass (kg) 0.568** 0.794** 0.797** 1
Android/gynoid fat ratio 0.624** 0.163** 0.594** 0.032
By CT
VAT (cm
2) 1 0.442** 0.813** 0.568**
SAT (cm
2) 0.442** 1 0.684** 0.794**
VAT/SAT 0.544** 20.413** 0.159** 20.137*
By cardiac CT angiography
Coronary artery stenosis 0.225** 20.098 0.201** 0.033
Biochemical data
Triglycerides (mg/dL) 0.211** 0.169* 0.238** 0.147*
HDL-cholesterol (mg/dL) 20.284** 20.049 20.224** 20.079
LDL-cholesterol (mg/dL) 0.036 0.108 0.063 0.112**
Fasting glucose (mg/dL) 0.207** 0.074 0.205** 0.035
Fasting insulin (mIU/mL) 0.488** 0.414** 0.478** 0.391**
HOMA-IR 0.514** 0.400** 0.509** 0.362**
A1C (%) 0.205** 0.120 0.244** 0.067
Adiponectin (mg/mL) 20.346** 20.110 20.276** 20.092
hsCRP (mg/dL) 0.075 20.057 0.023 0.006
**Correlation is significant at the 0.01 level (2-tailed).
doi:10.1371/journal.pone.0027694.t002
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fat accumulation [27], and have been used for investigations of
cardiovascular risk [28]. Adipose tissue in the android region
quantified by DXA has been found to have effects on plasma lipid
and lipoprotein concentrations[29] and correlate strongly with
abdominal visceral fat [30,31]. Thus, DXA is emerging as a
new standard for body composition assessment due to its high
precision, reliability and repeatability [32,33].
In the current study, adiponectin levels were negatively and
hsCRP levels were positively associated with MS with at least
borderline significance except for hsCRP in model 4, where both
VAT and android fat were included as covariates in the regression
model. The close relationship between hsCRP and VAT/android
fat may have attenuated the association between hsCRP and MS.
Mechanistically and theoretically, fat deposition in android area
is suggested to have deleterious effects on the heart function,
energy metabolism and development of atherosclerosis. However,
studies on android fat depot are limited [23]. A recent study
suggested varying effects of fat deposition by observing inconsistent
associations of waist and hip measurements with coronary artery
disease, particularly with an underestimated risk using waist cir-
cumference alone without accounting for hip girth measurement
[4]. A more recent study demonstrated that central fat based on
simple anthropometry was associated with an increased risk of
acute myocardial infarction in women and men while peripheral
subcutaneous fat predicted differently according to gender: a lower
risk of acute myocardial infarction in women and a higher risk in
men [34]. Another study with obese youth confirmed harmful
effects of android fat distribution on insulin resistance [35]. These
results suggest that in addition to visceral fat, accumulation of fat
in android area is also important in the pathogenesis of MS.
Of note, in this study, android fat was more closely associated
with a clustering of metabolic abnormalities than visceral fat.
There is no clear answer for this but several explanations can be
postulated. First, android area defined in this study includes liver,
pancreas and lower part of the heart. Many studies have shown
that fat accumulation in these structures have more detrimental
metabolic impacts through direct and indirect mechanisms
[36239]. For example, the adipokines released from pericardial
fat may act locally on the adjacent metabolically active organs and
Figure 2. Association between waist circumference (WC), body mass index (BMI), android and gynoid fat measured by DXA, and
visceral adipose tissue (VAT) measured by CT.
doi:10.1371/journal.pone.0027694.g002
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tion and stimulating the progression of atherosclerosis via outside-
to-inside signaling [40,41]. Furthermore, fat accumulation in liver
correlates more strongly with insulin sensitivity than visceral fat
via adipocytokine signaling and/or low-grade inflammation
mechanism [37,39].
Second, the android fat represents whole fat amount in the
upper abdomen area while VAT measurement was performed at a
single umbilicus level. This different methodology may possibly
contribute to greater association between metabolic impairments
and android fat than VAT. This interpretation is supported by the
borderline significance of VAT in the association with MS when
combined VAT area was used instead of a single level of VAT.
A recent study also showed that the whole fat amount between
L1–L5 vertebra showed a stronger relationship with insulin re-
sistance than that of the single L3 level [39].
In this study, both android fat amount and VAT were asso-
ciated with coronary artery stenosis. Android fat is closely related
with VAT because of their proximity and correlation with various
cardiovascular risk factors. The attenuated associations of both
variables without statistical significance in the regression model
where android fat and VAT were simultaneously included may be
due to a shared systemic effect as a result of shared risk factors for
the development of atherosclerosis.
This study has several strengths. First, DXA with its advanced
technology was used to measure regional fat depot. Second, the
subjects were recruited from a well-defined population, which
represented a single ethnic group and were older than 65 years.
Third, the regression analysis was adjusted for important factors
including whole body fat mass, insulin resistance, and biochemical
markers including adiponectin and hsCRP that might affect MS.
This study also has several limitations. First, since our study is
limited by its cross-sectional nature, it is impossible to confirm
clinically meaningful role of android fat depot. Therefore, further
studies are needed to determine a predictive role of android fat for
a clustering of cardiometabolic risk factors and subsequent inci-
dence of cardiovascular diseases. Second, this is a single cohort
study with a small number of subjects and the results are confined
to this specific cohort.
Table 3. Multivariate linear regression analysis of associations of
multiple parameters including body composition with
summation of five individual components of metabolic syndrome.
b
coefficient t P-value
Model 1: Age, gender, smoking, exercise, BMI, hsCRP, LDL-cholesterol,
adiponectin, HOMA-IR, and whole body fat mass adjusted
Age (years) 0.150 4.136 ,0.001
Gender (male vs. female) 0.210 4.229 ,0.001
BMI (kg/m
2) 0.211 3.429 0.001
hsCRP ($ 2.5 mg/l vs. ,2.5 mg/l) 0.187 3.012 0.034
Adiponectin (mg/mL) 20.225 26.002 ,0.001
HOMA-IR 0.200 4.850 ,0.001
Whole body fat mass (kg) 0.114 1809 0.071
Model 2: Model 1+VAT
Age (years) 0.121 2.743 0.006
Gender (male vs. female) 0.276 4.527 ,0.001
BMI (kg/m
2) 0.143 1.869 0.062
hsCRP ($ 2.5 mg/l vs. ,2.5 mg/l) 0.156 2.891 0.041
Adiponectin (mg/mL) 20.226 24.852 ,0.001
HOMA-IR 0.178 3.412 0.001
VAT (cm
2) 0.172 2.493 0.013
Model 3: Model 1+android fat
Age (years) 0.143 3.965 ,0.001
Gender (male vs. female) 0.275 5.204 ,0.001
BMI (kg/m
2) 0.207 3.399 0.001
hsCRP ($ 2.5 mg/l vs. ,2.5 mg/l) 0.142 2.528 0.063
Adiponectin (mg/mL) 20.194 25.094 ,0.001
HOMA-IR 0.173 4.153 ,0.001
Whole body fat mass (kg) 20.243 21.976 0.049
Android fat (kg) 0.384 3.381 0.001
Model 4: Model 1+VAT+android fat
Age (years) 0.119 2.712 0.007
Gender (male vs. female) 0.317 5.032 ,0.001
BMI (kg/m
2) 0.151 1.976 0.049
Adiponectin (mg/mL) 20.203 24.298 ,0.001
HOMA-IR 0.159 3.043 0.003
Android fat (kg) 0.378 2.404 0.017
HOMA-IR: homeostasis model assessment for insulin resistance.
doi:10.1371/journal.pone.0027694.t003
Table 4. Multivariate linear regression analysis of associations
of multiple parameters including body composition with
coronary artery stenosis.
b
coefficient t P-value
Model 1: Age, gender, smoking, exercise, BMI, hsCRP, LDL-cholesterol,
adiponectin, HOMA-IR, and whole body fat mass adjusted
Age (years) 0.237 4.308 ,0.001
Gender (male vs. female) 0.106 1.929 0.055
hsCRP ($ 2.5 mg/l vs. ,2.5 mg/l) 0.187 3.012 0.034
Adiponectin (mg/mL) 20.152 22.009 0.046
Whole body fat mass (kg) 0.114 1.809 0.071
Model 2: Model 1+VAT
Age (years) 0.262 3.726 ,0.001
Gender (male vs. female) 0.109 1.927 0.089
hsCRP ($ 2.5 mg/l vs. ,2.5 mg/l) 0.156 2.891 0.041
Adiponectin (mg/mL) 20.226 24.852 ,0.001
VAT (cm
2) 0.162 2.321 0.018
Model 3: Model 1+android fat
Age (years) 0.237 4.288 ,0.001
Gender (male vs. female) 0.105 1.884 0.060
hsCRP ($ 2.5 mg/l vs. ,2.5 mg/l) 0.142 2.528 0.056
Adiponectin (mg/mL) 20.294 25.094 ,0.001
Android fat (kg) 0.159 2.312 0.026
Model 4: Model 1+VAT+android fat
Age (years) 0.247 3.472 0.001
Gender (male vs. female) 0.123 1.993 0.042
hsCRP ($ 2.5 mg/l vs. ,2.5 mg/l) 0.102 1.528 0.063
Adiponectin (mg/mL) 20.158 22.087 0.038
HOMA-IR: homeostasis model assessment for insulin resistance.
doi:10.1371/journal.pone.0027694.t004
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Of the various body compositions examined using advanced
techniques, android fat measured by DXA was significantly
associated with clustering of five components of MS even after
accounting for various factors including visceral adiposity. It would
be interesting to apply this concept of body composition phe-
notypes to health risks in light of race/ethnic and age variability in
metabolic susceptibility to obesity and MS. Further studies are
necessary to determine whether the information gathered in the
present study is generalizable to other populations and also to
validate the practicality and implication of using android fat/DXA
in predicting for cardiovascular diseases.
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